Trial intelligence / Profile preview

FLAIR: MSFC and QoL in RRMS with Interferon beta-1a

NCT00534261Phase 4Completed

Sponsor
Biogen
Start
Nov 1999
Modality
Cytokines & Interferons
Countries
3
01

Overview

A Phase 4 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Biogen. Started Nov 1999; status: completed.

02

Drugs

interferon beta-1a
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on NCT00534261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00534261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call